Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 08, 2021 18:00 ET | Source: Novavax, Inc.

Novavax to Participate in H.C. Wainwright Virtual Global Life Sciences Conference Fireside Chat

GAITHERSBURG, Md., March 08, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that...
March 01, 2021 16:02 ET | Source: Novavax, Inc.

Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

96% vaccine efficacy against original COVID-19 in UK Phase 3 trialVaccine cross-protection demonstrated against both variants circulating in the UK and South AfricaFull enrollment (~30,000...
March 01, 2021 07:11 ET | Source: Novavax, Inc.

ノヴァヴァックスと武田がノヴァヴァックスのCOVID-19ワクチン候補のライセンス契約を確定し、武田は日本で第I/Ⅱ相試験を開始

日本での製造販売に向けて、武田へのCOVID-19ワクチン技術移転にも合意規制承認申請のため、武田が免疫原性および安全性試験で投薬開始メリーランド州ゲイザースバーグ発, March 01, 2021 (GLOBE NEWSWIRE) -- 重症感染症の次世代ワクチンを開発するバイオテクノロジー企業ノヴァヴァックス (Novavax, Inc.) (Nasdaq: NVAX)...
February 26, 2021 08:23 ET | Source: Novavax, Inc.

Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan

Agreement includes COVID-19 vaccine technology transfer to Takeda for local manufacturing and commercialization in JapanTakeda doses first participant in immunogenicity and safety study to support...
February 22, 2021 07:00 ET | Source: Novavax, Inc.

Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico

PREVENT-19 enrolls 30,000 volunteers across 118 sites in the U.S. and Mexico GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing...
February 18, 2021 16:02 ET | Source: Novavax, Inc.

Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine

Advances joint commitment from Novavax, Serum Institute of India and Gavi to ensure equitable access to NVX-CoV2373 worldwide across low-, middle- and high-income countriesMemorandum of understanding...
February 16, 2021 08:00 ET | Source: Novavax, Inc.

Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021

GAITHERSBURG, Md., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it...
February 15, 2021 20:04 ET | Source: Novavax, Inc.

Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million Doses of COVID-19 Vaccine for South Korea

GAITHERSBURG, Md., Feb. 15, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK Bioscience, a...
February 04, 2021 17:05 ET | Source: Novavax, Inc.

Novavax und die Regierung der Schweiz geben eine Grundsatzvereinbarung zur Bereitstellung des COVID-19-Impfstoffes bekannt

GAITHERSBURG, Maryland, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), ein Biotechnologieunternehmen, das Impfstoffe der nächsten Generation für schwere Infektionskrankheiten...
February 04, 2021 16:05 ET | Source: Novavax, Inc.

Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization

Rolling reviews have commenced by FDA, MHRA, EMA and Health Canada GAITHERSBURG, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing...

Next Page keyboard_arrow_right